SGE Consulting aims to optimize the market access process of innovative health technologies, at a national, regional or local level, from their clinical development phase through the marketing, the reimbursement and the monitoring to the post-marketing follow-up phases.
The evolution towards increasingly rigorous process and regulations, as well as the very tense economic environment , are both hurdles to access the healthcare market for innovative health technologies in Europe.
The complex and evolving environment in which health technologies progress, the multitude of market access channels, as well as the early and long term reimbursement pathways, force the stakeholders to identify at a very early stage the best suited opportunities for the development and the dissemination of their technology.
In this specific context, SGE Consulting is committed to best meet the needs of its clients by supporting them in all phases of market access.
SGE Consulting is a founding member of ASCAM-DM, the first association of consulting firms specialized in market access and reimbursement of medical devices in France. Sylvia GERMAIN is the current President.